Monica M. Bertagnolli, MD, Elected ASCO President for 2018–2019 Term
Monica M. Bertagnolli, MD, a long-time ASCO member and volunteer, has been elected to serve as the President of ASCO for the term beginning in June 2018. She will take office as President-Elect during the ASCO Annual Meeting in Chicago in June 2017. Additionally, three new members were elected to the ASCO Board of Directors, as well as two new members to the ASCO Nominating Committee.
“Serving as ASCO President is a tremendous personal honor for anyone in the field of oncology,” said Dr. Bertagnolli. “Much more importantly, it is an opportunity for me to make a meaningful difference by providing a strong voice in the health care community for those whom I consider to be my particular constituency: clinical and translational researchers, community and academic oncologists participating in clinical research, and surgical oncologists.”
An active ASCO member since 1995, Dr. Bertagnolli is Chief of the Division of Surgical Oncology at Dana-Farber/Brigham and Women's Cancer Center, Professor of Surgery at Harvard Medical School, and Associate Surgeon at Brigham and Women's Hospital and Dana-Farber Cancer Institute. Dr. Bertagnolli has served on the ASCO Board of Directors, the Cancer Prevention Committee, and the Strategic Planning Committee, among others.
Dr. Bertagnolli will be the first ASCO President-Elect to serve 4 years on the ASCO Board (1st year as President-Elect, 2nd year as President and Chair of the Board, 3rd year as Chair of the Board, and 4th year as Past President), following the Bylaws changes that were approved by members in May 2016.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
